Skip to main content

Table 1 Baseline characteristics according to the metabolic obesity phenotypes in a cross-sectional study of Hoveyzeh Cohort

From: The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study

Variables

Total

(N = 7464)

MHNO

(N = 2100)

MUNO

(N = 2468)

MHO

(N = 488)

MUO

(N = 2408)

P-value*

Age (years)

49.00 ± 9.25

47.60 ± 9.31

51.34 ± 9.69

45.51 ± 8.49

48.54 ± 8.49

< 0.001

Gender, male n (%)

2859 (38.3)

927 (44.1)

1182 (47.9)

106 (21.7)

644 (26.7)

< 0.001

Marital state n (%)

      

Single

270 (3.6)

111 (5.3)

75 (3.0)

19 (3.9)

65 (2.7)

< 0.001

Married

6500 (87.1)

1834 (87.3)

2127 (86.2)

436 (89.3)

2103 (87.3)

Ë‚0.001

Widow

561 (7.5)

117 (5.6)

225 (9.1)

23 (4.7)

196 (8.1)

Ë‚0.001

Divorced

133 (1.8)

38 (1.8)

41 (1.7)

10 (2.0)

44 (1.8)

Ë‚0.001

Current smoking, n (%)

1465 (19.6)

472 (22.5)

620 (25.1)

39 (8.0)

334 (13.9)

< 0.001

Residence Type (Urban/rural)

4725/2739

1140/960

1577/891

342/146

1666/742

Ë‚0.001

Education (years)

4.03 ± 4.98

4.18 ± 5.17

4.12 ± 5.07

4.50 ± 4.85

3.72 ± 4.23

0.001

Weight (kg)

77.68 ± 14.87

66.19 ± 10.20 a, b, c

73.28 ± 10.52 d, e

87.69 ± 12.09 f

90.17 ± 11.89

< 0.001

Height (cm)

164.13 ± 8.98

164.59 ± 9.25 a, b, c

165.76 ± 9.12 d, e

161.40 ± 8.50 f

162.62 ± 8.30

< 0.001

Waist circumference (cm)

99.7 ± 11.76

88.73 ± 7.62 a, b, c

97.12 ± 7.06 d, e

107.14 ± 9.55 f

110.41 ± 8.40

< 0.001

Hip circumference (cm)

104.10 ± 9.75

97.09 ± 6.51 a, b, c

99.88 ± 5.78 d, e

113.16 ± 7.49

112.72 ± 7.76

< 0.001

Wrist circumference (cm)

17.42 ± 1.31

16.67 ± 1.03 a, b, c

17.15 ± 1.08 d, e

17.88 ± 1.16 f

18.26 ± 1.28

< 0.001

Systolic blood pressure

113.11 ± 18.36

106.25 ± 13.61 a, c

116.91 ± 20.15 d

107.83 ± 12.11 f

116.27 ± 19.14

< 0.001

Diastolic blood pressure

71.38 ± 11.15

67.60 ± 9.24 a, b, c

73.15 ± 11.77 d

69.35 ± 8.81 f

73.25 ± 11.54

< 0.001

Heart rate

78.63 ± 9.58

77.02 ± 9.24 a, b, c

79.09 ± 10.05

78.38 ± 8.30 f

79.60 ± 9.45

< 0.001

Physical activity (MET)

36.90 ± 5.48

37.86 ± 5.98 a, c

36.52 ± 5.52 d

37.41 ± 4.90 f

36.35 ± 4.98

< 0.001

Diabetes, n (%)

1650 (22.1)

158 (7.5)

778 (31.5)

14 (2.9)

700 (29.1)

< 0.001

Dyslipidemia, n (%)

3227 (43.2)

425 (20.2)

1460 (59.2)

77 (15.8)

1265 (52.5)

< 0.001

Ischemic heart diseases, n (%)

986 (13.2)

188 (9)

356 (14.4)

55 (11.3)

387 (16.1)

< 0.001

Myocardial infarction, n (%)

129 (1.72)

18 (0.86)

53 (2.15)

5 (1.02)

53 (2.20)

0.001

Stroke, n (%)

124 (1.66)

17 (0.80)

52 (2.11)

5 (1.00)

50 (2.07)

0.001

  1. Data are means ± SD for quantitative variables and frequency (percent) for qualitative variables. MET: metabolic activity of task
  2. * ANOVA for quantitative variables, chi-square for qualitative variables
  3. a Significant difference between MHNW compared to MUNW.
  4. b Significant difference between MHNW compared to MHO.
  5. c Significant difference between MHNW compared to MUO.
  6. d Significant difference between MUNW compared to MHO.
  7. e Significant difference between MUNW compared to MUO.
  8. f Significant difference between MHO compared to MUO.